Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow20.11 M USD8.43 M USD-12.50 M USD-8.49 M USD-4.59 M USD6.64 M USD1.21 M USD2.35 M USD605122 USD-4.33 M USD-4.97 M USD-3.16 M USD
Depreciation & Amortization2.25 M USD5.16 M USD7.11 M USD6.78 M USD4.66 M USD2.04 M USD718000 USD338000 USD338682 USD368102 USD343218 USD258119 USD
Stock-Based Compensation22.99 M USD30.92 M USD31.67 M USD25.33 M USD13.96 M USD5.98 M USD3.04 M USD1.52 M USD1.27 M USD776994 USD511457 USD229679 USD
Capital Expenditures9.48 M USD3.23 M USD6.38 M USD10.38 M USD8.38 M USD1.96 M USD675000 USD500000 USD143767 USD143533 USD134012 USD589680 USD
Cash Flow from Investing-71.54 M USD58.30 M USD17.84 M USD-58.12 M USD-13.19 M USD-24.71 M USD-27.02 M USD-6.50 M USD-143767 USD392792 USD4.24 M USD-8.14 M USD
Cash Flow from Financing-10.92 M USD-6.78 M USD10.59 M USD16.32 M USD-2.78 M USD102.08 M USD1.60 M USD28.15 M USD4.80 M USD3.17 M USD368753 USD13.68 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow10.64 M USD5.20 M USD-18.88 M USD-18.87 M USD-12.98 M USD4.68 M USD538000 USD1.85 M USD461355 USD-4.47 M USD-5.11 M USD-3.75 M USD

Biolife Solutions Inc. is a leading provider of cell and gene therapy bioproduction tools and services. It specializes in offering biopreservation media, automated thawing devices, and storage solutions that are essential for preserving and transporting biological materials. The company's products help enhance the quality and stability of biological samples, which is crucial in sectors like regenerative medicine, biobanking, and drug discovery. By ensuring the safe handling and preservation of cells, tissues, and organs, Biolife Solutions plays a pivotal role in supporting life science research and clinical applications. The company's innovations contribute significantly to advancing therapeutic research and the development of treatments, thereby impacting the healthcare industry extensively. Headquartered in Bothell, Washington, Biolife Solutions Inc. is strategically positioned in the market, facilitating the evolving needs of the biopharmaceutical sector worldwide.